Fisher RI - Search Results

1

Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI. Miller TP, et al. Among authors: fisher ri. Semin Hematol. 1988 Apr;25(2 Suppl 2):17-22. Semin Hematol. 1988. PMID: 2456619

2

A Southwest Oncology Group perspective on the Revised European-American Lymphoma classification.

Grogan TM, Miller TP, Fisher RI. Grogan TM, et al. Among authors: fisher ri. Hematol Oncol Clin North Am. 1997 Oct;11(5):819-46. doi: 10.1016/s0889-8588(05)70465-2. Hematol Oncol Clin North Am. 1997. PMID: 9336717 Review.

3

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, LeBlanc M, Carlin S, Chase E, Fisher RI. Miller TP, et al. Among authors: fisher ri. N Engl J Med. 1998 Jul 2;339(1):21-6. doi: 10.1056/NEJM199807023390104. N Engl J Med. 1998. PMID: 9647875 Free article. Clinical Trial.

4

Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trial.

Taylor CW, LeBlanc M, Fisher RI, Moore DF Sr, Roach RW, Elias L, Miller TP. Taylor CW, et al. Among authors: fisher ri. Anticancer Drugs. 2000 Oct;11(9):695-700. doi: 10.1097/00001813-200010000-00004. Anticancer Drugs. 2000. PMID: 11129730 Clinical Trial.

5

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.

Weick JK, Dahlberg S, Fisher RI, Dana B, Miller TP, Balcerzak SP, Pierce HI. Weick JK, et al. Among authors: fisher ri. J Clin Oncol. 1991 May;9(5):748-53. doi: 10.1200/JCO.1991.9.5.748. J Clin Oncol. 1991. PMID: 1707955 Clinical Trial.

6

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.

Fisher RI, Longo DL, DeVita VT Jr, Hubbard SM, Miller TP, Young RC. Fisher RI, et al. Ann Oncol. 1991 Jan;2 Suppl 1:33-5. doi: 10.1093/annonc/2.suppl_1.33. Ann Oncol. 1991. PMID: 1710487 Free article. Review.

7

Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study.

Miller TP, Dahlberg S, Salmon SE, Williamson SK, Belt RJ, Dana BW, Fisher RI. Miller TP, et al. Among authors: fisher ri. J Clin Oncol. 1991 Jul;9(7):1204-9. doi: 10.1200/JCO.1991.9.7.1204. J Clin Oncol. 1991. PMID: 2045860 Clinical Trial.

8

Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

Fisher RI, Miller TP, Dana BW, Jones SE, Dahlberg S, Coltman CA Jr. Fisher RI, et al. Semin Hematol. 1987 Apr;24(2 Suppl 1):21-5. Semin Hematol. 1987. PMID: 2438778 Clinical Trial.

9

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.

Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP. Fisher RI, et al. Ann Oncol. 1994;5 Suppl 2:91-5. doi: 10.1093/annonc/5.suppl_2.s91. Ann Oncol. 1994. PMID: 7515652 Clinical Trial.

10

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial.

Dana BW, Dahlberg S, Miller TP, Hartsock RJ, Balcerzak S, Coltman CA, Carden JO, Hartley K, Fisher RI. Dana BW, et al. Among authors: fisher ri. J Clin Oncol. 1990 Jul;8(7):1155-62. doi: 10.1200/JCO.1990.8.7.1155. J Clin Oncol. 1990. PMID: 1694233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters